Australia's largest stock trading and investment forum Australia's #1 stock forum

Hard to really make a comparitive with Nico Labs and the...

First 572 Last

Share
Profile

Follow
sle

10,706 Posts.

339

19/02/23

12:34

Post #: 66333197
Share

Originally posted by green8: ↑

While it's nice to see the progress and the generous $3m government grant its missing the targeted hospitals for the 2023.
This statistic should be included for shareholders so we can keep management accountable.

A nice healthy cash balance and runway but it would be good to increase targeted spending imo to fast track sales. This sector is about getting into hospitals first, once you are in - you are in. First mover advantage.

Page 6 indicates we had approximate $1m (750k +$250) revenue run rate at end of 22, and have about $4.5m in sales opportunities already for 23. So, with an approximate 9 month sales lead time we could optimistically have a >$5m revenue run rate by year end.

Nice work cracking in the QLD health system and winning 12 hospitals. Now we are in this should expand and also generate referrals to other states and non government hospitals.

Good decision to target USA. Thats where the biggest health system is and also the largest capital markets for funding opportunities / buyouts.

It seems this is going to take a while to play out but our valuation should only increase with time.

Expand

Hard to really make a comparitive with Nico Labs and the competitiors to see what realistically we are currently and could be worth. Brainomix is probably the closest comparison given VIS AI and RAPID AI already have nearly or over 1500 hospitals. From memories Brainomix has 330 Hospitals.
Upvote

Reply